ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence.
Kurt Hong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.